Clinical Study

A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung Cancer

Table 4

CI and HI comparison of the 3D-CRT, IMRT, and SIB-IMRT groups.

PTViGTV
CIHICIHI

3D-CRT0.945 ± 0.041.28 ± 0.1
IMRT0.985 ± 0.0171.14 ± 0.05
SIB-IMRT2.30.986 ± 0.0150.998 ± 0.0041.09 ± 0.03
SIB-IMRT2.50.985 ± 0.0170.996 ± 0.0061.10 ± 0.05
SIB-IMRT2.70.986 ± 0.0170.990 ± 0.011.12 ± 0.0

compared with all other groups.
compared with the IMRT group.